Vav1-deficient mice are resistant to MOG-induced experimental autoimmune encephalomyelitis due to impaired antigen priming

Journal of Neuroimmunology

Volumn 139, Issue 1-2, 2003, Pages 17-26

  Korn, Thomas ^a,b   Fischer, Klaus Dieter ^c   Girkontaite, Irena ^c   Köllner, Gabriele ^a   Toyka, Klaus ^a   Jung, Stefan ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

EAE; Knockout; Signal transduction; T lymphocytes

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

EID: 0038546809     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00128-0     Document Type: Article

References (44)

1. Adams J., Houston H., Allen J., Lints T., Harvey R. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. Oncogene. 7:1992;611-618.
2. Anderton S., Radu C., Lowrey P., Ward E., Wraith D. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193:2001;1-11.
3. Archelos J., Jung S., Maurer M., Schmied M., Lassmann H., Tamatani T., Miyasaka M., Toyka K., Hartung H. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
4. Boguski M., Bairoch A., Attwood T., Michaels G. Proto-vav and gene expression. Nature. 358:1992;113.
5. Chan G., Hanke T., Fischer K. Vav-1 regulates NK T cell development and NK cell cytotoxicity. Eur. J. Immunol. 31:2001;2403-2410.
6. Costello P., Walters A., Mee P., Turner M., Reynolds L., Prisco A., Sarner N., Zamoyska R., Tybulewicz V. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. Proc. Natl. Acad. Sci. U. S. A. 96:1999;3035-3040.
7. Crespo P., Schuebel K., Ostrom A., Gutkind J., Bustelo X. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature. 385:1997;169-172.
8. del Pozo M., Vicente-Manzanares M., Tejedor R., Serrador J., Sanchez-Madrid F. Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 29:1999;3609-3620.
9. Eylar E., Kniskern P., Jackson J. Myelin basic proteins. Methods Enzymol. 32:1974;323-341.
10. Fischer H., Gjorloff A., Hedlund G., Hedman H., Lundgren E., Kalland T., Sjogren H., Dohlsten M. Stimulation of human naive and memory T helper cells with bacterial superantigen. Naive CD4+45RA+ T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J. Immunol. 148:1992;1993-1998.
11. Fischer K., Zmuldzinas A., Gardner S., Barbacid M., Bernstein A., Guidos C. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes. Nature. 374:1995;474-477.
12. Fischer K., Tedford K., Penninger J. Vav links antigen-receptor signaling to the actin cytoskeleton. Semin. Immunol. 10:1998;317-327.
13. Fischer K., Kong Y., Nishina H., Tedford K., Marengère L., Kozieradzki I., Sasaki T., Starr M., Chan G., Gardener S., Nghiem M., Bouchard D., Barbacid M., Bernstein A., Penninger J. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol. 8:1998;554-562.
14. Geginat J., Clissi B., Moro M., Dellabona P., Bender J., Pardi R. CD28 and LFA-1 contribute to cyclosporin A-resistant T cell growth by stabilizing the IL-2 mRNA through distinct signaling pathways. Eur. J. Immunol. 30:2000;1136-1144.
15. Girkontaite I., Missy K., Sakk V., Harenberg A., Tedford K., Potzel T., Pfeffer K., Fischer K. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2:2001;855-862.
16. Han J., Luby-Phelps K., Das B., Shu X., Xia Y., Mosteller R., Krishna U., Falck J., White M., Broek D. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 279:1998;558-560.
17. Hartung H., Schaefer B., Heininger K., Stoll G., Toyka K. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain. 111:1988;1039-1059.
18. Hehner S., Hofmann T., Dienz O., Droge W., Schmitz M. Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor- and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J. Biol. Chem. 275:2000;18160-18171.
19. Hjelmstrom P., Juedes A., Fjell J., Ruddle N. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161:1998;4480-4483.
20. Holsinger L., Graef I., Swat W., Chi T., Bautista D., Davidson L., Lewis R., Alt F., Crabtree G. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8:1998;563-572.
21. Hsu S., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
22. Juedes A., Hjelmstrom P., Bergman C., Neild A., Ruddle N. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 164:2000;419-426.
23. Julius M., Simpson E., Herzenberg L. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3:1973;645-649.
24. Kaga S., Ragg S., Rogers K., Ochi A. Activation of p21-CDC42/Rac-activated kinases by CD28 signaling: p21-activated kinase (PAK) and MEK kinase 1 (MEKK1) may mediate the interplay between CD3 and CD28 signals. J. Immunol. 160:1998;4182-4189.
25. Karandikar N., Vanderlugt C., Walunas T., Miller S., Bluestone J. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:1996;783-788.
26. Kong Y., Fischer K., Bachmann M., Mariathasan S., Kozieradzki I., Nghiem M., Bouchard D., Bernstein A., Ohashi P., Penninger J. Vav regulates peptide-specific apoptosis in thymocytes. J. Exp. Med. 188:1998;2099-2111.
27. Korn T., Toyka K., Hartung H., Jung S. Suppression of experimental autoimmune neuritis by leflunomide. Brain. 124:2001;1791-1802.
28. Krawczyk C., Penninger J. Molecular controls of antigen receptor clustering and autoimmunity. Trends Cell Biol. 11:2001;212-220.
29. Krawczyk C., Bachmaier K., Sasaki T., Jones G., Snapper B., Bouchard D., Kozieradzki I., Ohashi S., Alt W., Penninger M. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity. 13:2000;463-473.
30. Krawczyk C., Oliveira-dos-Santos A., Sasaki T., Griffiths E., Ohashi P., Snapper S., Alt F., Penninger J. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity. 16:2002;331-343.
31. Kuhns M., Epshteyn V., Sobel R., Allison J. Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12711-12716.
32. Lyons J., San M., Happ M., Cross A. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29:1999;3432-3439.
33. Mendel I., Kerlero de Rosbo N., Ben Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 29:1995;3432-3439.
34. Michel F., Mangino G., Attal-Bonnefoy G., Tuosto L., Alcover A., Roumier A., Olive D., Acuto O. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J. Immunol. 165:2000;3820-3829.
35. Mittrucker H., Shahinian A., Bouchard D., Kundig T., Mak T. Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J. Exp. Med. 183:1996;2481-2488.
36. Morrison W., Kennedy N., Offner H., Vandenbark A. Effects of anti-CD4 antibody: enhancement of lymph node PPD-memory T cell response. Cell. Immunol. 163:1995;106-112.
37. Movilla N., Dosil M., Zheng Y., Bustelo X. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42. Oncogene. 20:2001;8057-8065.
38. Muraille E., Devos S., Thielemans K., Urbain J., Moser M., Leo O. Costimulation regulates the kinetics of interleukin-2 response to bacterial superantigens. Immunology. 89:1996;245-249.
39. Raab M., Pfister S., Rudd C. CD28 signaling via VAV/SLP-76 adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity. 15:2001;921-933.
40. Salojin K., Zhang J., Delovitch T. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway. J. Immunol. 163:1999;844-853.
41. Tedford K., Nitschke L., Girkontaite I., Charlesworth A., Chan G., Sakk V., Barbacid M., Fischer K. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat. Immunol. 2:2001;548-555.
42. Turner M., Mee P., Walters A., Quinn M., Mellor A., Zamoyska R., Tybulewicz V. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity. 7:1997;451-460.
43. White J., Herman A., Pullen A., Kubo R., Kappler J., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 56:1989;27-35.
44. Wulfing C., Bauch A., Crabtree G., Davis M. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10150-10155.